Lataa...
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
A novel coronavirus SARS-CoV-2, also called novel coronavirus 2019 (nCoV-19), started to circulate among humans around December 2019, and it is now widespread as a global pandemic. The disease caused by SARS-CoV-2 virus is called COVID-19, which is highly contagious and has an overall mortality rate...
Tallennettuna:
| Julkaisussa: | bioRxiv |
|---|---|
| Päätekijät: | , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Cold Spring Harbor Laboratory
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7263507/ https://ncbi.nlm.nih.gov/pubmed/32511378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.04.20.051581 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|